March 16th 2023
Catatonia is thought to be significantly underrecognized, and it is important to routinely screen for it among hospitalized patients. Here's how to recognize and treat.
March 15th 2023
An Extra Cup: Caffeine Intake and Symptoms in Patients With Bipolar DisorderAugust 12th 2021
Doctor, can I have an extra cup of caffeine? Researchers performed a systematic review of studies of caffeine consumption and clinical symptoms in patients with bipolar disorder.
Valproic Acid: Overused in Bipolar Disorder?July 28th 2020
Valproate/divalproex appears to be considerably overused in the US; the use of lithium, second-generation antipsychotics, and carbamazepine should be more prominent in treatment decisions for patients with bipolar mania.
A Novel Approach to Contact TracingJune 11th 2020
COVID-19 has spurred many changes leading to wider adoption of various technologies to support public health efforts. But even data collected for the greater good can have unintended negative or punitive consequences.
Celebrating Progress, but Challenges RemainJanuary 30th 2020
With their early age of onset, high prevalence, chronicity, and pervasive impact on multiple domains of functioning, the burden of mood disorders exceeds that of virtually all medical conditions in the US and globally in terms of disability, cost, and suffering.
Mania and Hypomania: The Latest Thinking on Duration of Episodes and Other FeaturesOctober 29th 2019
An international task force of experts in the diagnosis and treatment of bipolar disorder was recently convened to address concerns about DSM-5 criteria, particularly the definitions of manic episodes. The DSM’s duration criteria is an area of concern.
Mixed Features, Suicide, and Adolescents at RiskSeptember 26th 2019
Assessment of suicidal risk in adolescents is a solemn professional obligation that involves obtaining as much information as possible from family members or caregivers. Evaluation of mood disorders is an essential part of the assessment.
Where There’s Smoke, There’s FireMay 31st 2018
The impetus to consider inflammation as potentially relevant to the pathoetiology of domain-based psychopathology (eg, anhedonia) and/or mental disorders, is provided by a confluence of factors discussed here.